Stat Consult

Sonidegib (Odomzo)

This slideshow reviews sonidegib (Odomzo), indicated for treatment of adult patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Trifluridine/Tipiracil (Lonsurf)

This slideshow reviews trifluridine/tipiracil, indicated for treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF biological therapy.

Rolapitant (Varubi)

This slideshow reviews rolapitant, indicated for prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

Filgrastim-sndz (Zarxio)

This slideshow reviews filgrastim-sndz (Zarxio), indicated to decrease the incidence of infection for patients receiving myelosuppressive anticancer drugs and also to reduce the time to neutrophil recovery and fever duration following induction or consolidation chemotherapy treatment for acute myeloid leukemia.

Plerixafor (Mozobil)

This slideshow reviews plerixafor (Mozobil), indicated for mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and multiple myeloma.

Dasatinib (Sprycel)

This slideshow reviews dasatinib (Sprycel), indicated for newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic lymphoma (ALL) with resistance or intolerance to prior therapy.

Clonazepam (Klonopin)

This slideshow reviews clonazepam (Klonopin), indicated for the treatment of panic disorder, with or without agoraphobia (as defined in DSM-IV), and seizure disorders.

Doxorubicin (Adriamycin)

This slideshow reviews doxorubicin (Adriamycin), indicated for the treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma.

Next hm-slideshow in Slides